Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope

PLoS Pathog. 2023 Aug 9;19(8):e1011554. doi: 10.1371/journal.ppat.1011554. eCollection 2023 Aug.

Abstract

Plasticity of influenza virus hemagglutinin (HA) conformation increases an opportunity to generate conserved non-native epitopes with unknown functionality. Here, we have performed an in-depth analysis of human monoclonal antibodies against a stem-helix region that is occluded in native prefusion yet exposed in postfusion HA. A stem-helix antibody, LAH31, provided IgG Fc-dependent cross-group protection by targeting a stem-helix kinked loop epitope, with a unique structure emerging in the postfusion state. The structural analysis and molecular modeling revealed key contact sites responsible for the epitope specificity and cross-group breadth that relies on somatically mutated light chain. LAH31 was inaccessible to the native prefusion HA expressed on cell surface; however, it bound to the HA structure present on infected cells with functional linkage to the Fc-mediated clearance. Our study uncovers a novel non-native epitope that emerges in the postfusion HA state, highlighting the utility of this epitope for a broadly protective antigen design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral* / chemistry
  • Antibodies, Viral* / metabolism
  • Epitopes
  • Hemagglutinin Glycoproteins, Influenza Virus / chemistry
  • Hemagglutinin Glycoproteins, Influenza Virus / metabolism
  • Humans
  • Influenza, Human*
  • Orthomyxoviridae*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Epitopes
  • Hemagglutinin Glycoproteins, Influenza Virus

Grants and funding

This work was supported by Japan Agency for Medical Research and Development grant (grant numbers JP22fk0108141 to Y.A., T.S. and Y.T., and JP223fa627009 to T.H.), by JSPS KAKENHI (grant numbers JP21J22416 to K.T., JP21K08192 to Y.A., JP20K20596 to T.H. and JP20K07545 to Y.T.), by Takeda science foundation (to Y.A.) and by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED (grant number JP22ama121001 to T.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.